Menu

Medical Whistleblower Advocacy Network

Human Rights Defenders

“All human beings are born free and equal in dignity and rights. They are endowed with reason and conscience and should act towards one another in a spirit of brotherhood.”

 Universal Declaration of Human Rights

Article 1

Visitors

641464

A Healing Codes Timer

“There is nothing more difficult to plan, more doubtful of success nor more dangerous to manage than the creation of a new order of things”

Niccolo Machiavelli

Dr. Loren Mosher MD Soteria Project

Soteria Project

Dr. Loren Mosher, in an interview for "Changing Our Minds" (http://www.changingourmindsmovie.com for complete DVD), a documentary on mental health, talks about the Soteria project, a long term study on alternative, non-neuroleptic drug treatments for schizophrenia

Misdiagnosis of Mental Illness

Story of M.S.

Published on Jan 2, 2013

M.S. asked the American Psychiatric Association in the ethics complaint she filed to redress the harm done to her by diagnoses from their manual, the DSM, and to prevent future harm to others. The APA summarily dismissed the complaint with no indication of considering its merits, saying that there is no appeal. Although the practitioners treating her were partly to blame, if the DSM were honestly described as largely unscientific and unlikely to help but likely to cause harm, how different her life would have been. Even today, for her to have told her story on the video herself would have been too risky, in light of the way people who have been psychiatrically diagnosed are treated. To see how you can help, go to psychdiagnosis.weebly.com

Advice from Dr. Grace E. Jackson MD

Methods to prevent or reduce the scope of these drug-induced tragedies should be a public health priority. Possible solutions include the avoidance and reduction of neurotoxic drugs; responsible prescribing practices; nutritional interventions; and the encouragement of life-enriching, health-sustaining behaviors.
Pharmaceutical Avoidance= the most prudent form of treatment for psychiatric patients
*avoids the use of neurotoxic drugs

Pharmaceutical Reduction= for active users of medication, the most prudent treatment involves harm reduction – a strategy of carefully modifying existing regimens by stopping drugs immediately when indicated; and by reducing doses as quickly as patients can safely tolerate

Responsible Use=whenever psychiatric drugs are prescribed, their use requires extensive preparation and medical knowledge
* avoiding neurotoxic drugs -- while this statement may seem like common sense, the current American health care system encourages (if not coerces) the use of brain-damaging treatments. This situation will not change until policy makers, administrators, hospitals, clinics, and others protect clinicians and patients who value safer, more effective treatments.

The Responsible Use of Psychiatric Drugs requires knowledge of information gleaned by methodical reviews of past medical records, and gleaned from unhurried, comprehensive interviews of the patient and/or patient’s caregivers.
  • Recipients of publicly funded mental health care, diagnosed with SMI (serious mental illness), have been suffering from multiple medical problems, in higher  percentages, than individuals without SMI.
  • On average, the seriously mentally illpatient dies 13 to 30 years earlier than expected, based upon the projected life expectancy in the USA.
  • Pharmaceuticals are a major part of the problem. Deaths due to adverse effects of prescription drugs are the #3 cause of death in the USA  each year.
  • Psychiatric drugs are contributing to the current and continuing “epidemic” of dementia.
 
Dr. Jackson, a Board certified psychiatrist, is a 1996 graduate of the University of Colorado School of Medicine. She holds degrees in biology and political science, as well as a Master's degree in Public Administration. Dr. Jackson completed her psychiatric internship and residency in the U.S. Navy, with subsequent assignment to Bethesda Naval Hospital as a staff physician. Since transitioning out of the military in spring 2002, Dr. Jackson has lectured widely in Europe and the United States, speaking about "The Unintended Consequences of Developing Biotechnologies"; "The History and Philosophy of Attention Deficit Disorder"; "Drug-Induced Psychiatric Emergencies"; and "The Limitations of Biological Psychiatry".
Articles:
http://psychrights.org/Drugs/DrJacksonUCELecture(UK)09.06.04.pdf

[pdf 2004 Lecture] ‘What Doctors May Not Tell You About Psychiatric Drugs’ by Grace E. Jackson, MD

Books:  Rethinking Psychiatric Drugs: A Guide for Informed Consent by Grace E. Jackson, MD

[2009] Drug-Induced Dementia: a perfect crime by MD Grace E. Jackson


1) the causal connection between antipsychotic drugs and Alzheimer's disease
2) the evidentiary link between stimulants (ADHD drugs) and shrinkage of the brain
3) the limitations of the neurogenesis theory of antidepressant action (in fact, Dr. Jackson discusses the research evidence which shows that antidepressants damage the hippocampus - the learning and memory center of the brain)
4) the evidence for mood stabilizers as neurodegenerative, rather than neuroprotective agents
5) the reasons why existing drug treatments are particularly hazardous for survivors of traumatic brain injury (i.e., soldiers with head injuries)

On-Line Resources Holistic Healing

Beyond Meds - Alternatives to Psychiatric Drugs 

On-Line Conference with Kelly Brogan Beyond Medication : Mental Health Holistic Healing and Nutrition  

Therapy on the Wild Side

 

Coognitvie Behavioral Techniques

"Those who profess to favor freedom, yet deprecate agitation, are men who want crops without plowing up the ground. They want rain without thunder and lightning. They want the ocean without the awful roar of its many waters. This struggle may be a moral one; or it may be a physical one; or it may be both moral and physical; but it must be a struggle. Power concedes nothing without a demand. It never did and it never will."

– Frederick Douglass, African-American abolitionist

Cognitive Behavioral Theapy CBT

CBT or Cognitive Behavioral Therapy has been found to be helpful to those suffering from PTSD.  Cognitive-behavioral therapy is based on the idea that our thoughts  cause our feelings and behaviors, not external things, like people, situations,   and events. CBT is Briefer and Time-Limited.  Clients understand at the very beginning of the therapy process that there will be a point when the formal therapy will end.  CBT therapists believe that the  clients change because they learn how to think differently and they act on that learning.  Therefore, CBT therapists focus on teaching rational self-counseling skills.   Most emotional and behavioral reactions are learned.  Therefore, the goal of therapy is to help clients unlearn their unwanted reactions and to learn a new way of reacting. 

For Further Information:  National Association of Cognitive-Behavioral Therapists http://www.nacbt.org/

Role Play CBT

Outsmarting Stress

Attachment and Resilence

Self EMDR

EMDR - Eye Movement Desensitization and Reprocessing

Eye Movement Desensitization and Reprocessing (EMDR)  is an integrative psychotherapy approach.  This therapy is based on information processing.  EMDR therapy discusses past experiences that trigger dysfunctional emotions, beliefs and sensations and the positive experience needed to better adaptive behaviors.    During the process the person pays attention to past memories and present triggers while focusing on a set of external stimulus.   The positive outcome is the emergence of insight, changes in memories and new associations.  

For Further Information: The EMDR Institute, Inc. http://www.emdr.com/index.htm

EMDR Bilateral Sound

Robert Whitaker

Robert Whitaker

Robert Whitaker, author of "Anatomy of an Epidemic" and "Mad in America", goes through the history of psychiatric medications and re-examines the research done on these drugs. His conclusions are disturbing to say the least.
www.madinamerica.com,

www.runciman.dk,

www.eksistentielpsykologi.dk

Dr. Peter Breggin

Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems. In short, it is not only dangerous to start taking psychiatric drugs, it can also be dangerous to stop them. Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision. Methods for safely withdrawing from psychiatric drugs are discussed in Dr. Breggin's new book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients, and Their Families.

Dr. Breggin’s book, Medication Madness (2008), which describes dozens of cases of otherwise self-controlled people who became spellbound by psychiatric drugs, leading them to perpetrate bizarre acts, including mayhem, murder and suicide.

Dr. Breggin’s medical book, Brain-Disabling Treatments in Psychiatry (2008),

Dr. Breggin’s most recent book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families (2013).Dr. Breggin’s most recent book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families (2013).

Tibetian Healing Sounds

Harm Reduction - Coming Off Psychiatric Drugs & Withdrawal

No one should stop taking psychiatric drugs without the assistance of a medical doctor.

 

The Icarus Project and Freedom Center provides a 40-page guide about reducing and coming off psychiatric medication. The Icarus Project 

 For more information and to download: http://theicarusproject.net/HarmReductionGuideComingOffPsychDrugs

 

Loren R. Mosher, Voyce Hendrix, with Deborah C. Fort, Soteria: Through Madness to Deliverance, ISBN Hardcover. 1-4134-6524-2, ISBN Softcover: 1-4134-6523-4
Published by Xlibris, Call 888-795-4274 ext. 876, to order. Order online at

www.xlibris.com, www.amazon.com, www.barnesandnoble.com

Lehmann, Peter (Hg.): Psychopharmaka absetzen. Erfolgreiches Absetzen von Neuroleptika, Antidepressiva, Phasenprophylaktika, Ritalin und Tranquilizern mit einem Vorwort von Loren Mosher (S. 11-13)

Lehmann, Peter (ed.): Coming off Psychiatric Drugs. Successful Withdrawal from Neuroleptics, Antidepressants, Lithium, Carbamazepine and Tranquilizers with a preface by Loren Mosher (pp. 15-17)

Πέτερ Λέμαν / Άννα Εμμανουηλίδου (Eds.): Βγαίνοντας από τα ψυχοφάρμακ – Εμπειρίες επιτυχημένης διακοπής νευροληπτικών, αντικαταθλιπτικών, λιθίου, καρβαμαζεπίνης και αγχολυτικών with a preface by Loren Mosher (pp. 24-26)

Wollschläger, Martin (Hg.): Sozialpsychiatrie. Entwicklungen – Kontroversen – Perspektiven mit dem Beitrag “Die Anwendung von therapeutischen Prinzipien der Soteria in der gemeindepsychiatrischen Versorgung” von Loren Mosher (S. 497-503)

Voiceless Movement: Deprived of Our Humanity. The Case against Neuroleptic Drugs with a foreword by Loren Mosher (pp. 15-17)

 

 

 

Jon Kabat Zinn

Applying Mindfulness in Depression

On the Wrong Tract

Dr. Peter Breggin

Dr. Peter Breggin

El Dr. Peter Breggin explica cómo actúan los psicofármacos en el cerebro, su función incapacitante y algunos de los efectos secundarios que pueden desencadenar. El Dr. Peter Breggin es autor de varios libros, incluyendo "Dejar los Psicofármacos, una guía para prescriptores, terapeutas, pacientes y sus familias".

Robert Whitaker

Who Can Fix Health Care?

Change your Mind

How your brain be calm

Calming Positive Energy

Alpha - Stim Devices

Alpha-Stim devices are categorized under Microcurrent Electrical Therapy (MET), and are FDA approved to treat anxiety, insomnia, depression, and pain. Alpha-Stim treats all types of acute, chronic, and post-traumatic pain. Alpha-Stim also offers relief from anxiety, depression, and insomnia and 9 out of 10 patients report significant improvements in these conditions. The Alpha-Stim M and AID devices are both about the size of a cell phone, (but a little thicker), and come with everything you need to get started: electrodes and earclip pads (for the AID device) and electrodes for the M device, Alpha Conducting Solution (to ensure a good electrical connection), two 1.5 volt batteries per device (AA for the M, and AAA for the AID), and a convenient lanyard for you to wear the Alpha-Stim device around your neck. It also includes an owner’s manual and a DVD that explains how to use the device and what kind of relief you can expect from it.

http://www.alpha-stim.com/alpha-stim-technology/faqs/

Harm Reduction Coming Off Psychiatric Drugs

Dolphin Dreams

References to Effective Non-Neuroleptic Treatment

 

Many thanks to Attorney Jim Gottstein for this list of resources - please see psychrights.org for additional information.

The Empathic Ward: Reality and Resistance in Mental Health Reform, by Leighton C. Whitaker, PhD, ABPP, and Arthur J. Deikman, MD, Ethical Human Psychology and Psychiatry, Vol. 11, No. 1:50-62 (2009).

Treating schizophrenia without drugs? There's good evidence for it. Comment: PsychMinded, by Tim Carlton, April 24, 2009.

Psychosocial treatment, antipsychotic postponement, and low-dose medication strategies in first-episode psychosis: A review of the literature, by John R. Bola, Klaus Lehtinen, Johan Cullberg and Luc Ciompi, Psychosis, Vol 1, No. 1: 4-18 (2009).

Effectiveness of Long-term Psychodynamic Psychotherapy: A Meta-analysis, by Falk Leichnsenring, DSe, Sven Rabung, PhD, Journal of the American Medical Association (JAMA), Vol 300, No. 13: 1551-1565 (2008).

Factors Involved in Outcome and Recovery in Schizophrenia Patients Not on Antipsychotic Medications: A 15-Year Multifollow-Up Study, A longitudinal study of 145 patients found a 40% recovery rate for those who did not take antipsychotics, versus a 5% rate for those who did, Journal of Nervous and Mental Disease, Vol 195, May, 2007, No. 5: 407-414

Five-year experience of first-episode nonaffective psychosis in open-dialogue approach: Treatment principles, follow-up outcomes, and two case studies, by Jaakko Seikkula, Jukka Aaltonen, Birgittu Alakare, Kauko Haarakangas, Jyrki Kera¨Nen, & Klaus Lehtinen, Psychotherapy Research, March 2006; 16(2): 214/228. This study of the Open Dialogue approach in Finland that used as little neuroleptics as possible found that in a group of 42 patients, 82% did not have psychotic symptoms at the end of five years, 86% had returned to their studies or jobs, and only 14% were on disability allowance. Only 29% had ever been exposed to a neuroleptic medication at all during the five years, and only 17% were on neuroleptics at the end of five years.

Open Dialogue Approach: Treatment Principles and Preliminary Results of a Two- year Follow-up on First Episode Schizophrenia, by Jaakko Seikkula, Birgitta Alakare, Jukka Aaltonen Juha Holma and Anu Rasinkangas, Ethical and Human Sciences and Services, 2003, 5(3), 163-182.

Open Dialogue in Psychosis II: A Comparison of Good and Poor Outcome Cases, by Jaakko Seikkula, Birgitta Alakare and Jukka Aaltonen, Journal of Constructivist Psychology, 14:267-284, 2001.

Recurrent Psychotic Depression Is Treatable by Psychoanalytic Therapy Without Medication, by Bertram P. Karon, PhD, Ethical Human Psychology and Psychiatry. Volume 7. Number I . SIJring 2005

Treatment of Schizophrenia Without Neuroleptics: Psychosocial Interventions Versus Neuroleptic Treatment, by Matt Irwin, Ethical Human Psychology and Psychiatry, Vol. 6, No. 2, Summer 2004.

Remember Our Heritage, by Cloe Madanes, Psychotherapy Networker, November/December 2004. 2.2 Megabytes. Reversal of Schizophrenia Without Neuroleptics, by Matt Irwin, Howard University Hospital, Ethical Human Psychology and Psychiatry, Volume 6, Number I, Spring 2004

The Tragedy of Schizophrenia without Psychotherapy, by Bertram P. Karon, PhD, Journal of The American Academy of Psychoanalysis und Dynamic Psychiatry, 31(1), 89- 118, 2003.

Soteria and Other Alternatives to Acute Psychiatric Hospitalization A Personal and Professional Review, by Loren R. Mosher, M.D., The Journal of Nervous and Mental Disease, 187:142-149, 1999.

Cognitive Therapy for the Prevention of Psychosis in People at Ultra-High Risk: Randomised Controlled trial, by Anthony P. Morrison, Paul French, Lara Walford, Shon W. Lewis, Aoiffe Kilcommons, Joanne Green, Sophie Parker and Richard P. Bentall, British Journal of Psychiatry, 2004;185, 291-7.

The Michigan State Psychotherapy Project study compared standard medication treatment for those diagnosed with severe schizophrenia with quality controlled psychotherapy both alone and with medication as an adjunct. The study demonstrated extremely more favorable long-term outcomes (at lower cost) for those receiving psychotherapy alone from psychotherapists with relevant training and experience.

Treatment of Acute Psychosis Without Neuroleptics: Two-Year Outcomes from the Soteria Project by John R. Bola, Ph.D., and Loren R. Mosher, M.D., Journal of Nervous Mental Disease, 191 (2003):219-29, finds that a relationally focused therapeutic milieu with minimal use of antipsychotic drugs, rather than drug treatment in the hospital, should be a preferred treatment for persons newly diagnosed with schizophrenia spectrum disorder.

Luc Ciompi, M.D., Professor Emeritus, MD, Switzerland The Soteria-concept. Theoretical bases and practical 13-yearexperience with a milieu-therapeutic approach of acute schizophrenia, Special lecture given at the 93 Annual Meeting of the Japanese Society of Psychiatry and Neurology, Tokyo, May 29th-31th, 1997, published in Psychiatria et Neurologia Japonica 99: 634-650, 1997.

The Concept of Affect Logic: An Integrative Psycho-Socio-Biological Approach to Understanding and Treatment of Schizophrenia, Psychiatry, Vol. 60, Summer 1997.

The Effects of Medicating or Not Medicating on the Treatment Process by Bertram P. Karon, Ph.D. discusses both the harm caused by neuroleptics and the efficacy of a psycho-dynamic process (2003). Longer version presented at Division of Psychoanalysis (39), American Psychological Association, New York, NY, April, 2002.

Psychotherapy with "Schizophrenia": Analysis of Metaphor to Reveal Trauma and Conflict, by Richard Shulman, PhD, Co-published simultaneously in The Psychotherapy Patient (The Haworth Press, Inc.) Vol. 9, No. 3/4, 1996, pp. 75-106; and: Psychosocial Approaches to Deeply Disturbed Persons (eds: Peter R. Breggin, and E. Mark Stern) The Hawthorn Press, Inc., 1996, pp.75-106.

The Benefits of Individual Psychotherapy for People Diagnosed with Schizophrenia: A Meta-Analytic Review by William H. Gottdiener and Nick Haslam, Ethical Human Sciences and Services, (2002) 4 (3), pp. 163-187. This comprehensive review of the literature finds that psychotherapy is as effective as medication and that adding medication does not increase effectiveness.

How Non-Diagnostic Listening Led to Rapid "Recovery:" from Paranoid Schizophrenia: What is Wrong With Psychiatry? by Al Sieberts, Ph.D. In this paper, Dr. Sieberts finds that Psychiatry lacks insight into its own behavior, invalidates constructive criticism, avoids the kind of self-examination it urges on "patients," shows little interest in accounts of successes with schizophrenic" individuals, erroneously lumps all the schizophrenias (plural) together in research studies, feels helpless and hopeless about schizophrenia, dismisses evidence that contradicts its inaccurate beliefs, and misrepresents what is known about "schizophrenia" to the public and to patients.

The Soteria Project: Twenty Five Years of Swimming Upriver, Loren R. Mosher, John R. Bola, Complexity and Change, (2000) 9: 68-74. This paper identifies the key ingredients to Soteria's success in treating patients diagnosed with schizophrenia without or with minimal medication.

Approaches to Madness Shared by Cross-Cultural Healing Systems and Strategic Family Therapy, by Madeleine Richeport-Haley, Journal of Family Psychotherapy, Vol 9(4), 61-75, 1998.

Recovery: The Lived Experience of Rehabilitation, by Patricia E. Deegan, Ph.D., revised version of paper originally published in Psychosocial Rehabilitation Journal, 1988, 11(4), 11-19. This very important paper describes in moving, personal terms the importance of hope in recovery. And willingness. And responsible action. It also provides very important information on how to structure a program to achieve recovery.

Soteria-California and Its Successors: Therapeutic Ingredients By Loren R. Mosher M.D., suggests that the strikingly beneficial effects of the Soteria type treatment are likely due to (a) the milieu, (b) attitudes of staff and residents, (c) quality of relationships, and (d) supportive social processes. Dr. Mosher also discusses how leadership effects the success of these programs.

Soteria Project: Final Progress Report, by Loren Mosher and Bob Vallone, 3/14/92. (9 megabytes) William Carpenter, Jr., "The treatment of acute schizophrenia without drugs: an investigation of some current assumptions," American Journal of Psychiatry, 134 (1977), 14-20. New Hope for People with Schizophrenia, Monitor on Psychology, Volume 31, No. 2, February 2000 discusses the growing evidence that people can and do recover from serious mental illness with the critical ingredient being psychosocial rehabilitation.

Psychoanalysis and Psychosis: Trends and Developments by Ann-Louise S. Silver, M.D Journal of Contemporary Psychotherapy, Vol 31, No. 1, Spring 2001. Psychodynamic work is too often dismissed as outmoded, while no theory has been developed that rivals it in effectiveness or in ability to offer cohesive theory.

Maurice Rappaport, "Are there schizophrenics for whom drugs may be unnecessary or contraindicated?" International Pharmacopsychiatry, 13 (1978), 100-111, concludes Many un-medicated-while-in-hospital patients showed greater long-term improvement, less pathology at follow-up, fewer re-hospitalizations and better overall function in the community than patients who were given chlorpromazine while in the hospital.

Psychoanalysis and Psychosis: Players and History in the United States, by Ann-Louise Silver M.D., Psychoanalysis and History 4(1), 2002. In this paper, Dr. Silver outlines how psychoanalysis has had significant success in treating schizophrenia and other psychoses since the early 1900's in the United States.

Treatment at Soteria House: A Manual for the Practice of Interpersonal Phenomenology, by Loren Mosher, Robert Vallone & Alma Menn,1992.

Deinstitutionalized Residential Care for the Mentally Disordered: The Soteria House Approach, by Holly Skodo Tilson, 1982, Grune & Stratton, Inc. Beware: 39 Megabytes.

Susan Mathews, “A non-neuroleptic treatment for schizophrenia: analysis of the two-year postdischarge risk of relapse,” Schizophrenia Bulletin, 5 (1979), 322-332 finds that at 12 months postdischarge, the cumulative probability of remaining well significantly favors the alternative Soteria program over the standard use of neuroleptics.

A Child Welfare Agency Project: Therapy for Families of Status Offenders, by Kenneth W. Michaels & Robert H. Green, Child Welfare, Vol LVIII. No.3:216-219 (1979).

Consumer Operated Support Programs Traditional community resources for mental health: a report of temple healing from India, by R Raguram, A Venkateswaran, Jayashree Ramakrishna, Mitchell G Weiss, British Medical Journal, v325 p38, 6 JULY 2002 bmj.com

Loren Mosher, “Community residential treatment for schizophrenia: two year followup,” Hospital and Community Psychiatry, 29 (1978), 715-723 finding that two years after discharge while the alternative Soteria program patients didn't show significantly different readmission rates or symptoms, they received medications significantly less often, used less outpatient care, showed significantly better occupational levels and were more able to live independently.

Effective Psychotherapy of Chronic Schizophrenia, by Nathaniel S. Lehrman, M.D., American Journal of Psychoanalysis, (1982), Vol.42, No. 2: 121-131. This 1982 paper presents the evidence already existing that over-reliance on neuroleptics was worsening outcomes. In this paper Dr. Lehrman discusses how individually tailored psychotherapy can get people who have chronically suffered schizophrenia well and back out into the community as a full member.

Relaxing Music

Articles, Etc., by Nathaniel S. Lehrman, MD

Nathaniel S. Lehrman, MD, began practicing psychiatry in 1947, and at various times had a full time office practice in psychotherapy, was the Clinical Director of Kingsboro Psychiatric Center in Brooklyn, New York, and Assistant Clinical Professor Psychiatry at Albert Einstein College of Medicine in the Bronx and Downstate Medical Center in Brooklyn, New York.  In 1963 Dr. Lehrman had his own experience from the patient side of psychiatry when he was hospitalized for paranoid schizophrenia.  Dr. Lehrman fully recovered and continued his psychiatric career, stating that key reasons for his recovery were running a mile a day in the hospital gym, playing his violin, and starting an intellectually challenging historical research project. 

 

Rethinking schizophrenia: its original nature, its drug-altered character, and thoughts about its treatment, by Nathaniel S. Lehrman, M.D., October, 2005

Do Our Hospitals Help Make Acute Schizophrenia Chronic?, by Nathaniel S. Lehrman, M.D., Diseases of the Nervous System, Vol. XXII, No. 9 (1961).

Schizophrenia: An Alternate View, by Nathaniel S. Lehrman, M.D., This Month in Mental Health, September, 1979, 6-7 Effective Psychotherapy of Chronic Schizophrenia, by Nathaniel S. Lehrman, M.D., American Journal of Psychoanalysis, (1982), Vol.42, No. 2: 121-131.

Psychiatrists and Drugs, by Nathaniel S. Lehrman, M.D., Letters to the Long Island Editor, The New York Times, March 11, 1984.

Public Mental Health Care and Its Problems: Two Important New Books--What they Include and What they Omit, by Nathaniel S. Lehrman, M.D., Psychiatric Quarterly, 62:4, 323-331 (1991).

Chronic Patients' Power Games and the Proper Setting of Limits, by Nathaniel S. Lehrman, M.D., Psychiatric Quarterly, 62:1 67-74 (1991).

Recognizing Some of Psychiatry's Errors, by Nathaniel S. Lehrman, M.D., Letter to The New York Times, January 26, 1992.

The Bureaucratic Destruction of Patients' Faith in Their Doctors: Public Psychiatry's Negative Lesson's for General Medicine, by Nathaniel S. Lehrman, M.D., Bulletin of the New York Academy of Medicine, 71:2, 194-217 (1994).

Commentary: Ethical Problems in Psychiatric Research, by Nathaniel S. Lehrman, M.D., and Vera Hassner Sharav, M.L.S., Journal of Mental Health Administration, 24:227-248 (1997).

The Rational Organization of Care for Disabling Psychosis: "If I Were Commissioner," by Nathaniel S. Lehrman, Ethical Human Sciences and Services, Vo. 5, No. 1:45-55 (2003)

The Dangers of Mental Health Screening, by Nathaniel S. Lehrman, M.D., Journal of American Physicians and Surgeons, Vol. 11, No. 3: 80-82 (2006). Interview; Psychiatry: 60 Years in an Increasingly Corrupt Specialty

Soteria Project

Schizophrenia & Non-Neuroleptic Tx

The current treatment for schizophrenia is based upon an outdated medical model. The Soteria Project, which utilized psychosocial treatment in a house-like setting for sufferers of schizophrenia showed that this disorder can be conquered without the use of neuroleptic or antipsychotic drugs.

“Too often we underestimate the power of a touch, a smile, a kind word, a listening ear, an honest compliment, or the smallest act of caring, all of which have the potential to turn a life around.”

― Leo Buscaglia

Medical Whistleblower Advocacy Network

MEDICAL WHISTLEBLOWER ADVOCACY NETWORK

P.O. 42700 

Washington, DC 20015

MedicalWhistleblowers (at) gmail.com

CONTACT


"Never impose on others what you would not choose for yourself."  Confucius

"It is not the critic who counts; not the man who points out how the strong man stumbles, or where the doer of deeds could have done them better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood; who strives valiantly; who errs, who comes short again and again, because there is no effort without error and shortcoming; but who does actually strive to do the deeds; who knows great enthusiasms, the great devotions; who spends himself in a worthy cause; who at the best knows in the end the triumph of high achievement, and who at the worst, if he fails, at least fails while daring greatly, so that his place shall never be with those cold and timid souls who neither know victory nor defeat."

Theodore Roosevelt- Excerpt from the speech "Citizenship In A Republic", delivered at the Sorbonne, in Paris, France on 23 April, 1910